The company is pulling 12 lots of its injection kits that contain the 19-gauge filter needle or the 18-gauge filter needle, according to a Sept. 29 post from the FDA.
Apellis is now exclusively distributing 18-gauge needle kits because “internal structural variations were identified in the specific 19-gauge x 1½ inch filter needle included in certain injection kits,” according to an Aug. 22 news release.
“A causal relationship has not been established between the structural variations in this 19-gauge filter needle and the rare events of retinal vasculitis,” according to the FDA’s post.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
